ADMS
D.E. Shaw & Co’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-293,428
| Closed | -$1.44M | – | 4408 |
|
|
2021
Q3 | $1.44M | Sell |
293,428
-175,432
| -37% | -$862K | ﹤0.01% | 2287 |
|
|
2021
Q2 | $2.48M | Buy |
468,860
+110,968
| +31% | +$586K | ﹤0.01% | 1927 |
|
|
2021
Q1 | $1.72M | Sell |
357,892
-318,234
| -47% | -$1.53M | ﹤0.01% | 1920 |
|
|
2020
Q4 | $2.93M | Buy |
676,126
+82,179
| +14% | +$356K | ﹤0.01% | 1572 |
|
|
2020
Q3 | $2.45M | Buy |
593,947
+409,847
| +223% | +$1.69M | ﹤0.01% | 1540 |
|
|
2020
Q2 | $471K | Buy |
184,100
+106,517
| +137% | +$273K | ﹤0.01% | 2181 |
|
|
2020
Q1 | $224K | Buy |
+77,583
| New | +$224K | ﹤0.01% | 2421 |
|
|
2019
Q4 | – | Sell |
-71,724
| Closed | -$367K | – | 2871 |
|
|
2019
Q3 | $367K | Buy |
+71,724
| New | +$367K | ﹤0.01% | 2189 |
|
|
2017
Q4 | – | Sell |
-22,526
| Closed | -$477K | – | 2704 |
|
|
2017
Q3 | $477K | Buy |
+22,526
| New | +$477K | ﹤0.01% | 2077 |
|
|
2016
Q1 | – | Sell |
-34,474
| Closed | -$976K | – | 2786 |
|
|
2015
Q4 | $976K | Buy |
34,474
+16,538
| +92% | +$468K | ﹤0.01% | 1766 |
|
|
2015
Q3 | $300K | Buy |
+17,936
| New | +$300K | ﹤0.01% | 2228 |
|
|
2014
Q4 | – | Sell |
-12,969
| Closed | -$241K | – | 2720 |
|
|
2014
Q3 | $241K | Sell |
12,969
-20,415
| -61% | -$379K | ﹤0.01% | 2122 |
|
|
2014
Q2 | $610K | Buy |
+33,384
| New | +$610K | ﹤0.01% | 1798 |
|